Join the Oncology Voice Network. Join for Free
How to Start a Diversity Equity & Inclusion Program in Pharma
Provide 5 keywords for SEO search separated by commas

How to Start a Diversity Equity & Inclusion Program in Pharma


Share This Article


Summary

In this episode, Tara Gonzalez joins to discuss the intricacies of establishing Diversity, Equity, and Inclusion (DEI) programs within organizations. She shares insights from her background and outlines the challenges and strategies for initiating DEI initiatives. Tara emphasizes the importance of structuring DEI functions and engaging the entire company, while highlighting the role of external consultants in conducting needs assessments. The conversation covers best practices, the necessity of leadership buy-in, and the ongoing development of DEI efforts. Tara concludes with valuable advice for those looking to implement DEI programs, providing a comprehensive overview of this crucial topic.

This episode features Tara Gonzales, Vice President Medical Affairs discusses how to start a DEI program in Pharma
Tara shares….

👉 How she stood up a DEI program from scratch
👉 Why there is such a need for DEI programs
👉 What companies can expect as far as impact of a well run DEI program
👉 What it takes to build a positive culture in a company

Click for Source
Provide 5 keywords for SEO search separated by commas

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Leveraging Creativity to Break into Your First MSL Role
Partner Avatar MSL Talk: Tom Caravela, Alec McCarthy

Leveraging Creativity to Break into Your First MSL Role

Press Release
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
OVN Avatar OVN Staff

Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN